Circulation

Journal

Publication Venue For

  • Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling..  140:1820-1833. 2019
  • Response by Lundberg et al to Letter Regarding Article, "Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell".  140:e760-e761. 2019
  • Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries.  140:1285-1287. 2019
  • Functionally Competent DNA Damage-Free Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair.  140:520-522. 2019
  • Response by Bansal et al to Letter Regarding Article, "dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".  139:E1035-E1036. 2019
  • Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity from the Red Blood Cell.  139:2654-2663. 2019
  • Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.  139:2542-2553. 2019
  • Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.  139:2422-2436. 2019
  • Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.  139:e56-e66. 2019
  • Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.  139:206-221. 2019
  • Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.  139:24-36. 2019
  • Letter by Russell and Janz Regarding Article, "Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability: A Prospective Multicenter Protocol-Directed Cohort Study".  138:2858-2859. 2018
  • 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  138:e740-e749. 2018
  • Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".  137:1300-1301. 2018
  • Heart disease and stroke statistics - 2018 update: A report from the American Heart Association.  137:E67-E492. 2018
  • PCSK9 variants, low-density lipoprotein cholesterol, and neurocognitive impairment reasons for geographic and racial differences in stroke study (REGARDS).  137:1260-1269. 2018
  • Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.  137:e30-e66. 2018
  • Early regenerative capacity in the porcine heart.  138:2798-2808. 2018
  • Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine.  137:1712-1730. 2018
  • Regenerative potential of neonatal porcine hearts.  138:2809-2816. 2018
  • Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease.  136:2325-2336. 2017
  • Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells.  136:2359-2372. 2017
  • Increased Inflammation in Pericardial Fluid Persists 48 Hours after Cardiac Surgery.  136:2284-2286. 2017
  • Interleukin-10 inhibits bone marrow fibroblast progenitor cell-mediated cardiac fibrosis in pressure-overloaded myocardium.  136:940-953. 2017
  • Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies a scientific statement from the American Heart Association.  136:e172-e194. 2017
  • An irregular wide complex tachycardia.  136:773-775. 2017
  • Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension.  136:440-450. 2017
  • Incident cardiovascular disease among adults with blood pressure <140/90 mm Hg.  136:798-812. 2017
  • Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease.  136:152-166. 2017
  • Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk): Insights from the Department of Veterans Affairs.  135:2572-2574. 2017
  • Response by Golwala et al to Letter Regarding Article, "implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".  135:e1200-e1202. 2017
  • Thresholds for Ambulatory Blood Pressure among African Americans in the Jackson Heart Study.  135:2470-2480. 2017
  • Added sugars and cardiovascular disease risk in children: A scientific statement from the American Heart Association.  135:e1017-e1034. 2017
  • Sources of sodium in US adults from 3 geographic regions.  135:1775-1783. 2017
  • Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (systolic blood pressure intervention trial) intensive blood pressure regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey).  135:1617-1618. 2017
  • Heart Disease and Stroke Statistics'2017 Update: A Report from the American Heart Association.  135:e146-e603. 2017
  • Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement from the American Heart Association.  135:e96-e121. 2017
  • Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.  135:201-203. 2017
  • Revised framingham stroke risk profile to reflect temporal trends.  135:1145-1159. 2017
  • Association between Duration of Resuscitation and Favorable Outcome after Out-of-Hospital Cardiac Arrest: Implications for Prolonging or Terminating Resuscitation.  134:2084-2094. 2016
  • Variations in Abdominal Aortic Aneurysm Care: A Report from the International Consortium of Vascular Registries.  134:1948-1958. 2016
  • Pleiotropic Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors?.  134:1695-1696. 2016
  • Abstract 18912: Platelet Derived Growth Factor Promotes Myofibroblastic Differentiation of Cardiac Resident Mesenchymal Stem Cells and Exacerbates Post-Infarction Left Ventricular Remodeling.  134:A18912. 2016
  • Abstract 20260: CD4<sup>+</sup> T- Lymphocyte Recruitment Into the Failing Heart is Indispensable for the Progression of Adverse Left Ventricular Remodeling.  134:A20260. 2016
  • Restoration of Hydrogen Sulfide Production in Diabetic Mice Improves Reparative Function of Bone Marrow Cells.  134:1467-1483. 2016
  • Should Patients with Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target?: A Protagonist View from the SPRINT Trial (Systolic Blood Pressure Intervention Trial).  134:1308-1310. 2016
  • Sedentary behavior and cardiovascular morbidity and mortality: A science advisory from the American Heart Association.  134:e262-e279. 2016
  • Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension.  134:858-860. 2016
  • Response to Letter Regarding Article, “MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis”.  133:e714-e714. 2016
  • Reproductive risk factors and coronary heart disease in the women's health initiative observational study.  133:2149-2158. 2016
  • Vascular toxicities of cancer therapies: The old and the new - An evolving avenue.  133:1272-1289. 2016
  • Response to Letter Regarding Article, "incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes: A decade in review".  133:e447. 2016
  • Response to Letter Regarding Article, "southern Dietary Pattern is Associated with Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".  133:e416. 2016
  • SPS3 Evidence Supports Intensive Blood Pressure Control.  133:552-554. 2016
  • Executive summary: Heart disease and stroke statistics-2016 update: A Report from the American Heart Association.  133:447-454. 2016
  • Heart disease and stroke statistics-2016 update a report from the American Heart Association.  133:e38-e48. 2016
  • Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.  133:256-264. 2016
  • Abstract 14883: Remodeling of the Mononuclear Phagocyte Network Underlies Chronic Inflammation and Disease Progression in Heart Failure: Importance of the Cardiosplenic Axis.  128:A14883. 2016
  • Abstract 19635: Glutathione-S-Transferase P Regulates Endothelial Progenitor Cell (EPC) Function in a c-Jun N-terminal kinase(JNK)-Dependent Manner and Enhances Neovascularization in Post-Infarction Heart Failure.  126:A19635. 2016
  • Abstract 19698: Altered Dendritic Cell Network in Chronic Heart Failure - Implications for Chronic Inflammation.  126:A19698. 2016
  • Abstract 17097: M2 Macrophage Polarization Promotes Neovascularization in vivo.  124:A17097. 2015
  • Abstract 17284: Selective Macrophage Ablation Attenuates Diet-Induced Obesity and Insulin Resistance and Reverses Diabetic Cardiomyopathy.  124:A17284. 2015
  • Abstract 18198: The Spleen Regulates Apoptotic Cell Clearance, Tissue Neovascularization, and Wound Healing After Myocardial Infarction.  132:A18198. 2015
  • Abstract 18244: Macrophages Infiltrate the Heart With Activation of Adaptive Immunity During Compensated Pressure Overload Hypertrophy.  132:A18244. 2015
  • Abstract 18821: Dysfunctional Regulatory T-Lymphocytes Promote Inflammation and Adverse Cardiac Remodeling in Chronic Ischemic Heart Failure.  132:A18821. 2015
  • Part 4: Systems of care and continuous quality improvement: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.  132:S397-S413. 2015
  • Part 7: Adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.  132:S444-S464. 2015
  • The National Physical Activity Plan: A Call to Action from the American Heart Association A Science Advisory from the American Heart Association.  131:1932-1940. 2015
  • Treatment of hypertension in patients with coronary artery disease: A scientific statement from the american heart association, american college of cardiology, and american society of hypertension.  131:e435-e470. 2015
  • Abstract P284: Exploring Differences in Self-Reported Moderate and Vigorous Physical Activity Among Hispanic Subgroups, Non-Hispanic Black, and Non-Hispanic White: National Health Interview Survey (NHIS), 1997-2012.  131:AP284-AP284. 2015
  • Heart disease and stroke statistics-2015 update : A report from the American Heart Association.  131:e29-e39. 2015
  • Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood the georgia stress and heart study.  131:1674-1681. 2015
  • Antibody-mediated rejection in cardiac transplantation: Emerging knowledge in diagnosis and management: A scientific statement from the American Heart Association: Endorsed by the international society for heart and lung transplantation.  131:1608-1639. 2015
  • Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis.  131:131-140. 2015
  • Association of fruit and vegetable consumption during early adulthood with the prevalence of coronary artery calcium after 20 years of follow-up.  132:1990-1998. 2015
  • Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial.  132:27-39. 2015
  • Executive summary: Heart disease and stroke statistics-2015 update : A report from the American Heart Association.  131:434-441. 2015
  • Incidence, cause, and comparative frequency of sudden cardiac death in national collegiate athletic association athletes a decade in review.  132:10-19. 2015
  • Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.  131:1202-1213. 2015
  • Left atrial mural endocarditis secondary to mitral valve jet lesion.  131:1529-1530. 2015
  • O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.  131:1260-1268. 2015
  • Response to letter regarding article, "the learning curve for transradial percutaneous coronary intervention among operators in the United States: A study from the national cardiovascular data registry".  131:e358. 2015
  • Southern dietary pattern is associated with hazard of acute coronary heart disease in the reasons for geographic and Racial Differences in Stroke (REGARDS) study.  132:804-814. 2015
  • Transdiaphragmatic rupture of hepatic abscess producing purulent pericarditis and pericardial tamponade.  131:e1-e2. 2015
  • Vitamin D therapy in individuals with prehypertension or hypertension the DAYLIGHT trial.  131:254-262. 2015
  • The Practical Use of the Latest Standards of Electrocardiography (PULSE) Trial: Nursing-focused intervention improves nurses' knowledge and quality of ECG monitoring 2014
  • Epigenome-wide association study of fasting blood lipids in the genetics of lipid-lowering drugs and diet network study.  130:565-572. 2014
  • Left anterior descending coronary artery occlusion secondary to metastatic squamous cell carcinoma presenting as st-segment-elevation myocardial infarction.  129. 2014
  • The learning curve for transradial percutaneous coronary intervention among operators in the united states: A study from the national cardiovascular data registry.  129:2277-2286. 2014
  • Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes.  129. 2014
  • Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.  129:1502-1509. 2014
  • Running forward new frontiers in endurance exercise biology.  129:798-810. 2014
  • Shared decision making in atrial fibrillation where we are and where we should be going.  129:704-710. 2014
  • Executive summary: Heart Disease and Stroke Statistics - 2014 Update: A report from the American Heart Association.  129:399-410. 2014
  • Heart Disease and Stroke Statistics - 2014 Update: A report from the American Heart Association.  129. 2014
  • Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation.  129:266-267. 2014
  • Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.  129:157-172. 2014
  • Association of low-grade albuminuria with adverse cardiac mechanics: Findings from the hypertension genetic epidemiology network (hypergen) study.  129:42-50. 2014
  • CD82 restrains pathological Angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells.  130:1493-1504. 2014
  • Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.  130:e118-e119. 2014
  • High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.  128:2364-2371. 2013
  • Secondary prevention of atherosclerotic cardiovascular disease in older adults: A scientific statement from the American heart association.  128:2422-2446. 2013
  • Age-Associated defects in epha2 signaling impair the migration of human cardiac progenitor cells.  128:2211-2223. 2013
  • Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.  128:1286-1297. 2013
  • Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.  128. 2013
  • AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: An analysis from the LDL-C assessment with proprotein convertase subtilisin kexin type 9 monoclonal antibody inhibition combined with statin therapy (LAPLACE)-thrombolysis in myocardial infarction (TIMI) 57 Trial.  128:962-969. 2013
  • Exercise standards for testing and training: A scientific statement from the American heart association.  128:873-934. 2013
  • Preliminary experience with social media for community consultation and public disclosure in exception from informed consent trials.  128:267-270. 2013
  • Mechanisms of cell therapy for clinical investigations: An urgent need for large-animal models.  128:92-94. 2013
  • Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention an updated report from the national cardiovascular data registry (2007-2012).  127:2295-2306. 2013
  • An egg-shaped cyst of the right interventricular septum.  127:2351-2352. 2013
  • Berlin heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children.  127:1702-1711. 2013
  • H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase.  127:1116-1127. 2013
  • Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study.  127:1128-1138. 2013
  • Functional consequences of human induced pluripotent stem cell therapy: Myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.  127:997-1008. 2013
  • Response to letter regarding article, magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: Implications beyond dimensions.  127. 2013
  • Executive summary: Heart disease and stroke statistics-2013 update: A Report from the American Heart Association.  127:143-152. 2013
  • Heart disease and stroke statistics-2013 update: A Report from the American Heart Association.  127. 2013
  • Synthetic ECG-gated cardiac computed tomography for in vivo imaging of the temporary total artificial heart.  127. 2013
  • The heart disease and stroke statistics-2013 update and the need for a national cardiovascular surveillance system.  127:21-23. 2013
  • Stroke after carotid stenting and endarterectomy in the carotid revascularization endarterectomy versus stenting trial (CREST).  126:3054-3061. 2012
  • Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling.  126:2720-2727. 2012
  • Platypnea-orthodeoxia syndrome as a presentation of hereditary hemorrhagic telangiectasia.  126:2645-2647. 2012
  • Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: A statement for health care professionals from the American association of cardiovascular and pulmonary rehabilitation and the American Heart Association.  126:2535-2543. 2012
  • Clinical and angiographic risk stratification and differential impact on treatment outcomes in the bypass angioplasty revascularization investigation 2 diabetes (BARI 2D) trial.  126:2115-2124. 2012
  • Third universal definition of myocardial infarction.  126:2020-2035. 2012
  • Population approaches to improve diet, physical activity, and smoking habits: A scientific statement from the American heart association.  126:1514-1563. 2012
  • Response to letter regarding article percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement.  126. 2012
  • Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management: A Scientific Statement From the American Heart Association.  126:1143-1172. 2012
  • Cardiac rehabilitation: Call to action for healthcare providers.  126:671-673. 2012
  • Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.  126:418-429. 2012
  • Energy balance and obesity.  126:126-132. 2012
  • Magnetic resonance imaging with 3-dimensional analysis of left ventricular remodeling in isolated mitral regurgitation: Implications beyond dimensions.  125:2334-2342. 2012
  • Response to letter to regarding article, "Effects of novel aldosterone synthase inhibitor for treatment of primary hypertension: Results of a randomized, double-blind, placebo- and active-controlled phase 2 trial".  125. 2012
  • Resistant hypertension: Incidence, prevalence, and prognosis.  125:1594-1596. 2012
  • Endothelial cells overexpressing interleukin-8 receptors reduce inflammatory and neointimal responses to arterial injury.  125:1533-1541. 2012
  • Increasing referral and participation rates to outpatient cardiac rehabilitation: The valuable role of healthcare professionals in the inpatient and home health settings: A science advisory from the american heart association.  125:1321-1329. 2012
  • Percutaneous coronary intervention in patients with severe aortic stenosis: Implications for transcatheter aortic valve replacement.  125:1005-1013. 2012
  • Executive summary: Heart disease and stroke statistics-2012 update: A report from the American heart association.  125:188-197. 2012
  • Heart disease and stroke statistics-2012 update: A report from the American heart association.  125. 2012
  • Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn?.  126:1401-1406. 2012
  • Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: A presidential advisory from the american heart association.  124:2951-2960. 2011
  • A Randomized Controlled Trial of beta 1-Receptor Blockade for Chronic Degenerative Mitral Regurgitation.  124. 2011
  • Is Small Change Significant? Association of Small Differences in Life's Simple 7 and Mortality: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  124. 2011
  • Primary outcomes for resuscitation science studies: A consensus statement from the american heart association.  124:2158-2177. 2011
  • Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: Results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.  124:1945-1955. 2011
  • Response to letter regarding article, "incidence of sudden cardiac death in national collegiate athletic association athletes".  124. 2011
  • Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).  124:1811-1818. 2011
  • Prevention of overweight/obesity as a strategy to optimize cardiovascular health.  124:840-850. 2011
  • Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trial.  123:2571-2578. 2011
  • ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the american college of cardiology foundation task force on clinical expert consensus documents.  123:2434-2506. 2011
  • Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association.  123:2292-2333. 2011
  • Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure.  123:1881-1890. 2011
  • Transmural heterogeneity and remodeling of ventricular excitation- contraction coupling in human heart failure.  123:1881-1890. 2011
  • Getting to the heart of myocardial stem cells and cell therapy.  123:1771-1779. 2011
  • Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: Primary results from the folic acid for vascular outcome reduction in transplantation trial.  123:1763-1770. 2011
  • Incidence of sudden cardiac death in national collegiate athletic association athletes.  123:1594-1600. 2011
  • Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A Guideline from the American Heart Association.  123:1243-1262. 2011
  • Heart disease and stroke statistics-2011 update: A report from the American Heart Association.  123. 2011
  • A Prospective Examination of the Obesity Paradox in Heart Failure: Insights from a Population Study.  122. 2010
  • A Prospective Population Study of the Rate and Risk of Hospitalization among Medicare-Eligible Community-Dwelling Older Adults with Incident Heart Failure.  122. 2010
  • Adiposity, Inflammation, and Risk for Death in Black and White Men and Women in the US: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  122. 2010
  • Colesevelam in Combination with Metformin Significantly Reduces Low-Density Lipoprotein Particle Concentration in Patients with Early Type 2 Diabetes.  122. 2010
  • Increased Protein O-GlcNAcylation Inhibits TNF-alpha-Induced NFkB Signaling in Rat Aortic Smooth Muscle Cells.  122. 2010
  • Inhibition of STIM1 Oligomerization by Protein O-Linked N-Acetylglucosamine: A Novel Metabolically Mediated Regulation of Cardiomyocyte Calcium Overload.  122. 2010
  • Is the Obesity Epidemic Reversing Favorable Trends in Blood Pressure: Evidence from Cohorts Born between 1890 and 1990 in the United States.  122. 2010
  • Life's Simple 7 in 2003-2007 and Mortality in Blacks and Whites: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  122. 2010
  • Native Endothelium Mimicking Self-Assembled Nanomatrix for Drug-Eluting Stents.  122. 2010
  • Part 8: Adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.  122. 2010
  • Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the bypass angioplasty revascularization investigation 2 diabetes trial.  122:1690-1699. 2010
  • Part 6: Defibrillation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations..  122:S325-S337. 2010
  • Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations..  122:S422-S465. 2010
  • Composite cell sheets: A further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.  122. 2010
  • Myectomy plus alfieri technique for outflow tract obstruction in hypertrophic cardiomyopathy.  122:938-939. 2010
  • Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans.  122:138-144. 2010
  • Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.  121:1912-1925. 2010
  • Heart disease and stroke statistics--2010 update: a report from the American Heart Association..  121. 2010
  • Executive summary: Heart disease and stroke statistics-2010 update: A report from the american heart association.  121. 2010
  • Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure.  121:252-258. 2010
  • Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction.  121:293-305. 2010
  • Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the bypass angioplasty revascularization investigation 2 diabetes trial.  120:2550-2558. 2009
  • Stem cells for myocardial repair with use of a transarterial catheter.  120. 2009
  • Native Endothelium Mimicking Self-Assembled Nanomatrix for Drug Eluting Stents.  120:S951-S951. 2009
  • Simultaneous Transmural Mapping of Voltage and Calcium in the Human Heart.  120:S667-S667. 2009
  • Simultaneous Transmural Measurements of V-m and Ca-j(2+) During Rapid Pacing and Long-Duration Ventricular Fibrillation in Canine Hearts.  120:S689-S689. 2009
  • ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the american college of cardiology foundation/american heart association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): Developed in collaboration with the american academy of family physicians.  120:1296-1336. 2009
  • Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-κb-dependent pathway.  120:1222-1230. 2009
  • Mortality, health outcomes, and body mass index in the overweight range: A science advisory from the american heart association.  119:3263-3271. 2009
  • Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia.  119:2708-2717. 2009
  • Stem cell therapy for heart failure: Are arrhythmias a real safety concern?.  119:2735-2740. 2009
  • Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.  119:2545-2552. 2009
  • Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American heart association.  119:2408-2416. 2009
  • MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.  119:2357-2366. 2009
  • Distribution and Determinants of Doppler-Derived Diastolic Flow Indices in African Americans: The Jackson Heart Study.  119:E340-E340. 2009
  • Divergent tumor necrosis factor receptor-related remodeling responses in heart failure:Role of nuclear factor-κB and inflammatory activation.  119:1386-1397. 2009
  • Racial and Geographic Differences in Self-Reported Moderate or More Physical Activity: The REasons for Geographic And Racial Differences in Stroke (REGARDS).  119:E344-E344. 2009
  • Ionizing radiation in cardiac imaging: a science advisory from the American Heart Association Committee on Cardiac Imaging of the Council on Clinical Cardiology and Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention..  119:1056-1065. 2009
  • Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee.  119:480-486. 2009
  • Heart disease and stroke statistics - 2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee.  119:480-486. 2009
  • Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease. The coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis.  119:382-389. 2009
  • Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition.  118:1970-1978. 2008
  • Natural Endothelium Mimicking Self-Assembled Nanomatrix for Drug Eluting Stent Applications.  118:S962-S962. 2008
  • Transition from chronic compensated to acute d compensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures.  118:1433-1441. 2008
  • Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: Results of the multicenter trial of the orqis medical cancion system for the enhanced treatment of heart failure unresponsive to medical therapy (MOMENTUM).  118:1241-1249. 2008
  • Population-based prevention of obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance: A scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for prevention (formerly the expert panel on population and prevention science).  118:428-464. 2008
  • Marginally increased waist circumference predicts hypertension prevalence among normal and overweight adults: The REGARDS study.  117. 2008
  • Angina pectoris: Reversal of the gender gap.  117:1505-1507. 2008
  • Heart disease and stroke statistics-2008 Update: A report from the American heart association statistics committee and stroke statistics subcommittee.  117. 2008
  • Heme oxygenase-1 and carbon monoxide in vascular pathobiology: Focus on angiogenesis.  117:231-241. 2008
  • Proarrhythmic aspects of atrial fibrillation surgery: Mechanisms of postoperative macroreentrant tachycardias.  117:155-162. 2008
  • Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium..  118. 2008
  • The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation.  117:1189-1200. 2008
  • Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model.  116:1113-1119. 2007
  • Stromal cell-derived factor-1α confers protection against myocardial ischemia/reperfusion injury: Role of the cardiac stromal cell-derived factor-1α-CXCR4 axis.  116:654-663. 2007
  • Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase Cε-p44/42 mitogen-activated protein kinase-pSer-signal transducers and activators of transcription1/3 pathway.  116:535-544. 2007
  • Resistance exercise in individuals with and without cardiovascular disease: 2007 update: A scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism.  116:572-584. 2007
  • Core components of cardiac rehabilitation/secondary prevention programs: 2007 update - A sci. statement from the Am. Heart Assoc. exercise, cardiac rehabilitation, and prevention comm., the council on clinical cardiology; the councils on cardiovascular nursing, epidemiology and prevention, and nutrition, physical activity, and metabolism; and the Am. Assoc. of Cardiovasc. and Pulmonary Rehabil..  115:2675-2682. 2007
  • Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: Effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death.  115:2442-2450. 2007
  • Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention.  115:2761-2788. 2007
  • Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.  115:1866-1875. 2007
  • Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update.  115:1481-1501. 2007
  • Medication adherence does not explain disparities in blood pressure control: The reasons for geographic and racial differences in stroke (REGARDS) study.  115:E288-E288. 2007
  • Perceived stress and depression: The impact of race and residence in the "Black Belt" region of the Southeastern United States.  115:E275-E276. 2007
  • The national prevalence of healthy lifestyles is low and varies by race and geographic region.  115:E280-E280. 2007
  • Trust in the patient-physician relationship is related to care-seeking behavior following stroke symptoms: The REasons for geographic and racial differences in stroke (REGARDS) study.  115:E259-E260. 2007
  • Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: The coronary artery risk development in young adults study.  115:1004-1011. 2007
  • Effect of high-dose atorvastatin on hospitalizations for heart failure: Subgroup analysis of the Treating to New Targets (TNT) study.  115:576-583. 2007
  • Heart disease and stroke statistics - 2007 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  115. 2007
  • Essential features of a surveillance system to support the prevention and management of heart disease and stroke: A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease.  115:127-155. 2007
  • Aldosterone and cardiovascular disease: Smoke and fire.  114:2572-2574. 2006
  • Trends in acute myocardial infarction in 4 US States between 1992 and 2001: Clinical characteristics, quality of care, and outcomes.  114:2806-2814. 2006
  • Continuity of epicardial activation during ventricular fibrillation in the isolated swine heart.  114:330-330. 2006
  • Protein O-glycosylation improves survival and effects cytokine release following trauma-hemorrhage in rats.  114:426-426. 2006
  • Relationship between aspirin, statins, the combination and C-reactive protein.  114:828-829. 2006
  • Human ventricular fibrillation: Wandering wavelets, mother rotors, or both?.  114:530-532. 2006
  • The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.  114:894-904. 2006
  • Chordal cutting does not adversely affect left ventricle contractile function.  114. 2006
  • Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients.  114. 2006
  • Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms.  113:1888-1904. 2006
  • Pulsology rediscovered: Commentary on the Conduit Artery Function Evaluation (CAFE) study.  113:1162-1163. 2006
  • You can't judge a book by its cover.  113:1275-1277. 2006
  • Racial differences in intensity of hypertension treatment: The reasons for geographic and racial disparities in stroke study.  113:E309-E309. 2006
  • Relationship for stroke and heart disease between the average Framingham Risk Scores with cause-specific mortality at the state level.  113:E312-E312. 2006
  • Heart disease and stroke statistics - 2006 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.  113. 2006
  • Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.  113:544-554. 2006
  • Cell-based cardiac repair reflections at the 10-year point.  112:3174-3183. 2005
  • ICAM-1 governs angiogenesis via regulation of eNOS activity: Role of glutathione and PTEN.  112:U156-U156. 2005
  • Modified lipoprotein-immune complexes and progression of internal carotid intima-media thickness in type 1 diabetes.  112:U848-U849. 2005
  • Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.  112:2668-2676. 2005
  • Role of the protein kinase C-ε-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning.  112:1971-1978. 2005
  • Mutations in transforming growth factor-β receptor type II cause familial thoracic aortic aneurysms and dissections.  112:513-520. 2005
  • Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits.  111:3112-3118. 2005
  • Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart.  111:2066-2072. 2005
  • Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: The LIFE (Losartan Intervention for Endpoint reduction in hypertension) study.  111:1924-1931. 2005
  • Differences in predicted 10-year risk of stroke by region and race.  111:E212-E213. 2005
  • High prevalence of stroke symptoms in a general population without a history of stroke or TIA: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  111:E213-E213. 2005
  • National distribution of C-reactive protein in African-Americans and whites: The reasons for geographic and racial differences in stroke (REGARDS) study.  111:E226-E226. 2005
  • Gender and peri-procedural stroke and death following carotid artery stenting: An update from the CREST lead-in phase.  111:E49-E49. 2005
  • Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E-/- mice fed a chow diet.  110:3715-3720. 2004
  • D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.  110:3252-3258. 2004
  • Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis.  110:2831-2836. 2004
  • Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group II: age-dependent risk factors for obesity and comorbidities..  110. 2004
  • Protection from ischemic and hypovolemic injury by hyperglycemia transduced by hexosamine biosynthesis and O-linked N-acetylglucosamine on cytoplasmic proteins.  110:1099-1099. 2004
  • Role of microscopic tissue structure in shock-induced activation assessed by optical mapping in myocyte cultures.  110:98-98. 2004
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.  110:1960-1966. 2004
  • Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?.  110:1626-1631. 2004
  • Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries.  110:1664-1669. 2004
  • Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.  110:292-300. 2004
  • Hypertensive therapy: Part I.  109:2953-2958. 2004
  • Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).  109:2993-2999. 2004
  • Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.  109:2857-2861. 2004
  • Neurological events during long-term mechanical circulatory support for heart failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience.  109:2423-2427. 2004
  • Intramural virtual electrodes in ventricular wall: Effects on epicardial polarizations.  109:2349-2356. 2004
  • Resumption of Electrical Conduction in Previously Isolated Pulmonary Veins: Rationale for a Different Strategy?.  109:1226-1229. 2004
  • Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report from the Women's Ischemia Syndrome Evaluation (WISE) Study.  109:706-713. 2004
  • C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice.  109:647-655. 2004
  • Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.  109:672-693. 2004
  • Estradiol and Progestins Differentially Modulate Leukocyte Infiltration after Vascular Injury.  109:234-241. 2004
  • Hypertensive therapy: Part II..  109:3081-3088. 2004
  • Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice..  109:3215-3220. 2004
  • Does the stroke risk of stenting increase at older ages? Thirty-day stroke - Death rates in the CREST lead-in phase.  108:461-461. 2003
  • Increased oxidation of free fatty acids does not lead to increased susceptibility to ischemia in hearts from type-2 diabetic rats.  108:17-17. 2003
  • Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation.  108. 2003
  • Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation..  108 Suppl 1:II111-II115. 2003
  • Transplantation of autologous fresh bone marrow into infarcted myocardium: A word of caution.  108. 2003
  • Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution..  108 Suppl 1:II247-II252. 2003
  • Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.  108:512-515. 2003
  • Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis.  108:143-149. 2003
  • A test of an innovative approach to develop a national cohort to address racial and geographic disparities in stroke.  107:E7020-E7021. 2003
  • Five-year changes in carotid intimal-medial thickness are highly correlated between arteries and among wall segments.  107:E7036-E7036. 2003
  • Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: Implications in the antiproliferative response to rapamycin.  107:911-916. 2003
  • Use of emergency medical services in acute myocardial infarction and subsequent quality of care: Observations from the national registry of myocardial infarction 2.  106:3018-3023. 2002
  • Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).  106:2537-2542. 2002
  • Differential modulation of lactate, pyruvate and glucose oxidation by insulin and dichloroacetate.  106:195-196. 2002
  • Optical mapping of V-m and Ca-i(2+) during arrhythmias induced by local perfusion of norepinephrine in cultured cell monolayers.  106:192-192. 2002
  • Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction.  106. 2002
  • Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction..  106:I131-I136. 2002
  • Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.  106:1127-1132. 2002
  • Intramural virtual electrodes during defibrillation shocks in left ventricular wall assessed by optical mapping of membrane potential.  106:1007-1014. 2002
  • Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.  106:854-859. 2002
  • Mitochondrial integrity and function in atherogenesis.  106:544-549. 2002
  • Defending the rationale for the two-tailed test in clinical research.  105:3062-3065. 2002
  • Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/progestin Replacement Study (HERS).  105:2962-2967. 2002
  • Mild renal insufficiency is associated with angiographic coronary artery disease in women.  105:2826-2829. 2002
  • Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation.  105:2253-2258. 2002
  • BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.  105:1348-1353. 2002
  • Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues.  105:849-854. 2002
  • Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.  105:290-292. 2002
  • Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: Evidence from the mouse carotid artery ligation model.  104:2740-2745. 2001
  • Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction.  104:2641-2644. 2001
  • Association of a gene polymorphism for PAI-1 with primary pulmonary hypertension.  104:604-604. 2001
  • Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?.  104. 2001
  • Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?.  104:I223-I228. 2001
  • Genetic and environmental contributions to platelet aggregation: The Framingham Heart Study.  103:3051-3056. 2001
  • Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty.  103:2935-2941. 2001
  • High-energy phosphate metabolism and creatine kinase in failing hearts: A new porcine model.  103:1570-1576. 2001
  • Improvement of defibrillation efficacy and quantification of activation patterns during ventricular fibrillation in a canine heart failure model.  103:1473-1478. 2001
  • Insulin resistance and five-year progression of carotid intimal-medial wall thickness: The Insulin Resistance Atherosclerosis Study (IRAS).  103:1349-1349. 2001
  • Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.  103:1012-1016. 2001
  • Hormone replacement therapy and stroke: Are the results surprising?.  103:620-622. 2001
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the stroke council of the American Heart Association.  103:163-182. 2001
  • Intramyocardial transplantation of autologous myoblasts: Can tissue processing be optimized?.  102. 2000
  • Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?.  102:III210-III215. 2000
  • Microcirculatory effects of blocking cell adhesion molecules in transgenic sickle cell mice..  102:307-307. 2000
  • Septum acts as a partial barrier to wavefronts during ventricular fibrillation.  102:341-341. 2000
  • Shock-induced arrhythmias assessed using mapping of transmembrane potential and intracellular calcium in myocyte cultures.  102:341-341. 2000
  • The role of calcium current in the nonlinear changes of transmembrane potential during defibrillation shocks.  102:340-340. 2000
  • Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)..  102:42-47. 2000
  • Estrogen attenuates integrin-β3-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.  101:2949-2955. 2000
  • Chronic β-adrenergic stimulation induces myocardial proinflammatory cytokine expression.  101:2338-2341. 2000
  • Estrogen-induced vasoprotection is estrogen receptor dependent: Evidence from the balloon-injured rat carotid artery model.  101:2342-2344. 2000
  • Mechanism of ventricular defibrillation: The role of tissue geometry in the changes in transmembrane potential in patterned myocyte cultures.  101:2438-2445. 2000
  • beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling..  101:2103-2109. 2000
  • β-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.  101:2103-2109. 2000
  • Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries.  101:1362-1365. 2000
  • Influence of postshock epicardial activation patterns on initiation of ventricular fibrillation by upper limit of vulnerability shocks.  101:1329-1336. 2000
  • Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias: Evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias.  101:624-630. 2000
  • Essential hypertension part II: Treatment.  101:446-453. 2000
  • Essential hypertension. Part I: Definition and etiology.  101:329-335. 2000
  • Bradykinin in the heart: Friend or foe?.  100:2305-2307. 1999
  • Harriet Pearson Dustan..  100:2122-2123. 1999
  • Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery.  100. 1999
  • Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery..  100:II340-II344. 1999
  • Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants.  100. 1999
  • Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants..  100:II345-II350. 1999
  • Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events.  100. 1999
  • Anisotropy of membrane polarization decreases when an electrode is separated from the myocardial surface.  100:786-786. 1999
  • Electrotonic suppression of early and delayed afterdepolarizations in electrically coupled, isolated ventricular myocytes.  100:846-846. 1999
  • Heart failure changes activation patterns during ventricular fibrillation.  100:838-839. 1999
  • Organizational changes in atrial fibrillation produced by a single radiofrequency ablation lesion remain local to the lesion site.  100:341-342. 1999
  • Primary prevention of high blood cholesterol in the US, 1887-1994.  100:740-740. 1999
  • Radiofrequency ablation of the right atrium reduces atrial defibrillation thresholds and changes fibrillatory activity.  100:65-65. 1999
  • Ventricular fibrillation characteristics are different in different species.  100:310-310. 1999
  • Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro.  100:1639-1645. 1999
  • Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension.  99:3266-3271. 1999
  • Opening of potassium channels the common cardioprotective link between preconditioning and natural hibernation?.  99:3079-3085. 1999
  • Evidence for angiotensin-converting enzyme- and chymase-mediated angiotensin II formation in the interstitial fluid space of the dog heart in vivo.  99:2583-2589. 1999
  • Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement..  99:2480-2484. 1999
  • Guide to preventive cardiology for women.  99:2480-2484. 1999
  • Women versus men regarding outcome of CABG or PTCA [6] (multiple letters).  99:1925-1926. 1999
  • Carotid artery elasticity varies directly with educational achievement level: The ARIC Study, 1987-1992..  99:1112-1112. 1999
  • Insulin sensitivity and systemic atherosclerosis.  99:1115-1115. 1999
  • Predictors of inflammatory status in a middle-aged population.  99:1108-1108. 1999
  • Trends in severity of hospitalized myocardial infarction: The ARIC study 1987-1994..  99:1104-1104. 1999
  • Myocardial oxygenation during high work states in hearts with postinfarction remodeling.  99:942-948. 1999
  • Identification of a novel genetic locus for familial cardiac myxomas and Carney complex.  98:2560-2566. 1998
  • Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease.  98:2248-2254. 1998
  • Can cellular transplantation improve function in doxorubicin-induced heart failure?.  98. 1998
  • Can cellular transplantation improve function in doxorubicin-induced heart failure?.  98:II151-II155. 1998
  • ACE-I therapy improves 30-day survival in Medicare patients recently hospitalized with congestive heart failure (CHF).  98:811-812. 1998
  • Alterations of intra-myocyte ion content correlate with post-cardioplegia electrophysiologic recovery.  98:750-750. 1998
  • Effect of defibrillation shocks on transmembrane potential in strands of cultured myocytes.  98:52-52. 1998
  • In vivo cardiac energetics in GLUT4-null mice.  98:627-628. 1998
  • Primary prevention of high blood pressure in the US, 1959-1994..  98:657-657. 1998
  • Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads.  98:1517-1524. 1998
  • Better outcome for women compared with men undergoing coronary revascularization: A report from the bypass angioplasty revascularization investigation (BARI).  98:1279-1285. 1998
  • Images in cardiovascular medicine. Improvement of myocardial perfusion after transmyocardial laser revascularization and coronary artery bypass graft surgery..  98:728-729. 1998
  • Adenosine pretreatment of human myocardium and ischemic preconditioning [2] (multiple letters).  97:2279. 1998
  • Pathophysiology of sudden coronary death in women: Implications for prevention.  97:2103-2105. 1998
  • Evidence for association and genetic linkage of the angiotensin- converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study.  97. 1998
  • Myocardial discontinuities: A substrate for producing virtual electrodes that directly excite the myocardium by shocks.  97:1738-1745. 1998
  • Locally propagated activation immediately after internal defibrillation.  97:1401-1410. 1998
  • Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2.  97:1150-1156. 1998
  • Atherosclerosis in type 2 diabetic and non-diabetic subjects with and without previous myocardial infarction: The insulin resistance atherosclerosis study (IRAS).  97:817-817. 1998
  • Could a decrease in the correlation between CVD risk factors underlie their smaller estimated impact on CVD in the elderly?.  97:823-823. 1998
  • Effect of postmenopausal hormone therapy on carbohydrate metabolism.  97:831-831. 1998
  • Stroke incidence rates: Seven year follow-up of the atherosclerosis risk in communities (ARIC) cohort.  97:824-824. 1998
  • The multiple metabolic syndrome: Increased clustering versus increased prevalence?.  97:831-831. 1998
  • Left ventricular thrombus.  97:412. 1998
  • Carotid stenting and angioplasty: A statement for healthcare professionals from the councils on cardiovascular radiology, stroke, cardio- thoracic and vascular surgery, epidemiology and prevention, and clinical cardiology, American Heart Association.  97:121-123. 1998
  • Predictive power of the relative lymphocyte concentration in patients with advanced heart failure.  97:19-22. 1998
  • No role for NO in estrogen-mediated vasoprotection?.  96:2769-2771. 1997
  • Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: The FACT study.  96:3396-3402. 1997
  • Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery.  96. 1997
  • Does transplantation of cardiomyocytes improve function of infarcted myocardium?.  96:II-188-93. 1997
  • Does transplantation of cardiomyocytes improve function of infarcted myocardium?.  96. 1997
  • Effects of biphasic shocks on the spatial distribution of the transmembrane potential.  96:688-688. 1997
  • Excitation of cardiac tissue by defibrillation shocks: Role of microscopic tissue geometry.  96:683-683. 1997
  • Intravenous amiodarone increases ventricular fibrillation organization without increasing wavelength.  96:4188-4188. 1997
  • L-arginine protects against xanthine oxidase-dependent vascular injury in hypercholesterolemic rabbits.  96:2327-2327. 1997
  • Quantitative characteristic of reentrant pathways change during the first 44 seconds of ventricular fibrillation.  96:687-687. 1997
  • Local delivery of ethanol inhibits intimal hyperplasia in pig coronary arteries after balloon injury.  96:2295-2301. 1997
  • Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial.  96:2162-2170. 1997
  • Estrogen restores endothelial cell function in an experimental model of vascular injury.  96:1624-1630. 1997
  • Regional disparities in the incidence of elevated blood pressure among young adults: The CARDIA study.  96:1082-1088. 1997
  • Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy.  96:334-343. 1997
  • Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group..  95:1479-1486. 1997
  • Aortic plaque morphology and vascular events: A follow-up study in patients with ischemic stroke.  96:3838-3841. 1997
  • Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty: The ACCORD Study.  95:83-89. 1997
  • Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension.  95:1479-1486. 1997
  • Elective stenting of the extracranial carotid arteries.  95:376-381. 1997
  • Preconditioning of human myocardium with adenosine during coronary angioplasty.  95:2500-2507. 1997
  • Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging.  95:390-394. 1997
  • Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment.  95:1301-1307. 1997
  • Transesophageal echocardiographic assessment of papillary muscle rupture [6] (multiple letters).  96:2737-2738. 1997
  • Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group..  94:2883-2889. 1996
  • Can grafted cardiomyocytes colonize peri-infarct myocardial areas?.  94. 1996
  • Can grafted cardiomyocytes colonize peri-infarct myocardial areas?.  94:II337-II340. 1996
  • Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants.  94. 1996
  • Evidence for an involvement of the neutrophil integrin lymphocyte function-associated antigen-1 in early failure of heart transplants..  94:II254-II259. 1996
  • Predictors of reversibility of pulmonary hypertension in cardiac transplant recipients in the first postoperative year.  94. 1996
  • Differential postshock activation pattern of successful and failed defibrillation shocks of the same shock strength.  94:3325-3325. 1996
  • Quantitative analysis of the effects of dofetilide on ventricular fibrillation activation fronts and its relationship to defibrillation threshold in pigs.  94:1429-1429. 1996
  • Stationary reentrant circuits are rare during ventricular fibrillation in pigs.  94:271-271. 1996
  • Insulin Sensitivity and Atherosclerosis.  93:1809-1817. 1996
  • Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators..  93:1809-1817. 1996
  • Relation between activated clotting time during angioplasty and abrupt closure.  93:667-671. 1996
  • Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery.  93:577-584. 1996
  • Ethnic differences in carotid wall thickness: The insulin resistance atherosclerosis study (IRAS).  93:P25-P25. 1996
  • Passive and active smoking are related to progression or atherosclerosis.  93:22-22. 1996
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease.  94:1537-1544. 1996
  • Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model MRI and 31P-MRS study.  94:1089-1100. 1996
  • Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery.  94:2221-2227. 1996
  • Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994: A multi-institutional study.  94:2883-2889. 1996
  • Transesophageal echocardiographic assessment of papillary muscle rupture.  94:1003-1009. 1996
  • Selection and treatment of candidates for heart transplantation: A statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology, American Heart Association.  92:3593-3612. 1995
  • Asymptomatic cardiac ischemia pilot (ACIP) study: Improvement of cardiac ischemia at 1 year after PTCA and CABG.  92. 1995
  • Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion. A clinical study..  92:II354-II358. 1995
  • Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass.  92. 1995
  • Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass..  92:II334-II340. 1995
  • Postextrasystolic mechanical restitution in closed-chest dogs: Effect of heart failure.  92:2652-2659. 1995
  • ANODAL AND CATHODAL POINT STIMULATION PRODUCE ACTION-POTENTIAL PROLONGATION IN REGIONS OF DEPOLARIZATION.  92:1431-1431. 1995
  • DIRECT LINK BETWEEN GAP JUNCTION REMODELING AND CHANGES IN CONDUCTION IN CULTURED MYOCYTES.  92:189-189. 1995
  • RELATION BETWEEN GAP JUNCTION DISTRIBUTION AND ANISOTROPIC ACTIVATION SPREAD IN CULTURED MONOLAYERS OF NEONATAL RAT MYOCYTES.  92:188-188. 1995
  • Effects of premature beats on repolarization of postextrasystolic beats.  92:1969-1980. 1995
  • Bioenergetic consequences of left ventricular remodeling.  92:1011-1019. 1995
  • Chronic hypoxia differentially regulates α1-adrenergic receptor subtype mRNAs and inhibits α1-adrenergic receptor-stimulated cardiac hypertrophy and signaling.  92:918-925. 1995
  • Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: Results from the TIMI II study.  91:2541-2548. 1995
  • Cardiovascular health at the crossroads: outlook for the 21st century. Presented at the 67th Scientific Sessions of the American Heart Association November 4, 1994 Dallas, Texas..  91:1304-1310. 1995
  • Images in cardiovascular medicine. Coarctation of the aorta and ventricular septal defect..  91:1263. 1995
  • DOES THE ASSOCIATION OF RISK-FACTORS AND ATHEROSCLEROSIS CHANGE WITH AGE - A COMBINED ANALYSIS OF THE ARIC AND CHS COHORTS.  91:931-931. 1995
  • IS THE STROKE BELT DISAPPEARING - AN ANALYSIS OF RACIAL AND TEMPORAL EFFECTS.  91:938-938. 1995
  • Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake: A 31P NMR spectroscopic study.  92:1274-1283. 1995
  • Effect of tachycardia heart failure on the restitution of left ventricular function in closed-chest dogs.  91:176-185. 1995
  • Fighting the NIH funding crisis.  91:2502. 1995
  • Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion: A clinical study.  92. 1995
  • Impact of acute pulmonary rejection on cardiac function.  91:186-191. 1995
  • Preventing heart attack and death in patients with coronary disease.  92:2-4. 1995
  • Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions?.  90. 1994
  • Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions?.  90:II275-II279. 1994
  • Metabolic and functional evidence that retrograde warm blood cardioplegia does not injure the right ventricle in human beings..  90:II310-II315. 1994
  • 2-DIMENSIONAL HIGH-RESOLUTION OPTICAL MAPPING OF ANISOTROPIC IMPULSE CONDUCTION IN NEONATAL RAT-HEART CEL MONOLAYERS.  90:40-40. 1994
  • CALCULATION OF ABSOLUTE METABOLIC FLUXES IN THE PERFUSED RAT-HEART BY C-13 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY.  90:629-629. 1994
  • CONDUCTION-VELOCITY AND SHAPE OF ACTION-POTENTIAL UPSTROKE IN A COMPUTER-MODEL OF AN ANISOTROPIC HEART CELL MONOLAYER.  90:411-411. 1994
  • PLASMA-CONCENTRATIONS OF LP(A) DISTINGUISH FEMALE BUT NOT MALE CORONARY-DISEASE CASES FROM CONTROLS.  90:509-509. 1994
  • Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction..  90:2103-2114. 1994
  • RACIAL-DIFFERENCES IN CAROTID-ARTERY WALL THICKNESS IN MIDDLE-AGED ADULTS.  89:939-939. 1994
  • SOCIOECONOMIC-STATUS AFFECTS THE EXCESS BLACK STROKE MORTALITY - THE NATIONAL-LONGITUDINAL-MORTALITY-STUDY.  89:939-939. 1994
  • Endothelin in human congestive heart failure.  89:1580-1586. 1994
  • Intramachine and intermachine variability in transesophageal color Doppler images of pulsatile jets: In vitro studies.  89:2141-2149. 1994
  • Metabolic and functional evidence that retrograde warm blood cardioplegia does not injure the right ventricle in human beings.  90:310-315. 1994
  • Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.  90:2468-2473. 1994
  • Mononuclear cells from dogs with acute lung allograft rejection cause contraction of pulmonary arteries.  90:952-958. 1994
  • The role of coronary tone and increased demand in daily ischemia [1].  89:2454-2455. 1994
  • Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction.  90:2103-2114. 1994
  • Influence of left ventricular assist on valvular regurgitation..  88:II309-II318. 1993
  • Report of the task force on children and youth. American Heart Association..  88:2479-2486. 1993
  • Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial..  88:1484-1494. 1993
  • TISSUE GEOMETRY AS A DETERMINANT OF UNIDIRECTIONAL CONDUCTION BLOCK - ASSESSMENT OF MICROSCOPIC EXCITATION SPREAD BY OPTICAL MAPPING IN PATTERNED MYOCYTE CULTURES.  88:623-623. 1993
  • Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).  88:92-100. 1993
  • Natriuretic peptide system in human heart failure.  88:1004-1009. 1993
  • Race and prognosis after myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial.  88:1484-1494. 1993
  • Report of the task force on children and youth.  88:2479-2485. 1993
  • Subsets of ambulatory myocardial ischemia based on heart rate activity: Circadian distribution and response to anti-ischemic medication.  88:92-100. 1993
  • Failure of cryopreserved homograft valved conduits in the pulmonary circulation.  86. 1992
  • Failure of cryopreserved homograft valved conduits in the pulmonary circulation..  86:II150-II153. 1992
  • Rejection after cardiac transplantation. A time-related risk factor analysis..  86:II236-II241. 1992
  • Surgical connections from ventricle to pulmonary artery. Comparison of four types of valved implants..  86:II154-II158. 1992
  • Surgical connections from ventricle to pulmonary artery: Comparison of four types of valved implants.  86. 1992
  • ALTERATIONS IN MYOCARDIAL GLUCOSE-METABOLISM IN DIABETES-INDUCED HEART-FAILURE.  86:281-281. 1992
  • DISCONTINUOUS IMPULSE PROPAGATION AT A CELLULAR-LEVEL IN CULTURED STRANDS OF NEONATAL RAT-HEART CELLS.  86:752-752. 1992
  • OPTICAL VERSUS ELECTRICAL DETECTION OF RAPID MEMBRANE-POTENTIAL CHANGES IN CULTURED NEONATAL RAT-HEART CELLS.  86:820-820. 1992
  • PASSIVE SMOKING AND CAROTID-ARTERY WALL THICKNESS - THE ARIC STUDY.  85:862-862. 1992
  • Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: Results of a multicenter trial.  85:942-949. 1992
  • Cardiac transplantation: Recipient selection, donor procurement, and medical follow-up: A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.  86:1061-1079. 1992
  • Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study.  86:1206-1216. 1992
  • Coronary angioplasty in cardiac transplant patients: Results of a multicenter study.  86:458-462. 1992
  • Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) registry.  86:446-457. 1992
  • Effect of intravenous adenosine infusion on myocardial perfusion and function: Hemodynamic/angiographic and scintigraphic study.  86:887-895. 1992
  • Familial lipoprotein disorders in patients with premature coronary artery disease.  85:2025-2033. 1992
  • Importance of intraluminal pressure on hemodynamics and vasoconstriction responses of stenotic arteries.  85:708-716. 1992
  • Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia: Evidence for involvement of perinodal myocardium within the reentrant circuit.  85:1675-1688. 1992
  • Echocardiographic assessment of prosthetic valves..  84:I228-I239. 1991
  • Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.  84:1107-1117. 1991
  • Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.  84:2398-2408. 1991
  • Immediate versus deferred β-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) II-B study.  83:422-437. 1991
  • Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function.  84:1819-1827. 1991
  • Usefulness of transesophageal echocardiography in assessment of aortic dissection.  84:1903-1914. 1991
  • Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans.  82. 1990
  • Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans..  82:IV390-IV396. 1990
  • DECLINING STROKE MORTALITY - ESTIMATES OF THE RELATIVE ROLE OF INCIDENCE AND CASE FATALITY.  81:712-712. 1990
  • TREATMENT OF OBESITY HYPERTENSION.  81:723-723. 1990
  • Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator: Results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial.  81:1457-1476. 1990
  • Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms.  82:1962-1972. 1990
  • Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans.  82. 1990
  • Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS).  82:1647-1658. 1990
  • Two-dimensional echocardiography and Doppler color flow mapping in the diagnosis and prognosis of ventricular septal rupture.  81:1775-1783. 1990
  • Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study..  80:III19-III24. 1989
  • Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up..  80:III140-III146. 1989
  • Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study.  80:19-24. 1989
  • Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up.  80:140-146. 1989
  • Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry.  79:1171-1179. 1989
  • Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase or deferoxamine. A 31P nuclear resonance study..  78:III164-III172. 1988
  • Cardioplegic arrest superimposed on evolving myocardial ischemia. Improved recovery after inhibition of hydroxyl radical generation by peroxidase of deferoxamine. A 31P nuclear resonance study.  78. 1988
  • Cryosurgical ablation of atrioventricular nodal reentry: Histologic localization of the proximal common pathway.  77:1356-1362. 1988
  • Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Protective effects of deferoxamine..  76:V180-V185. 1987
  • Calibration of color Doppler flow mapping during extreme hemodynamic conditions in vitro: A foundation for a reliable quantitative grading system for aortic incompetence.  75:837-846. 1987
  • Color Doppler assessment of mitral regurgitation with orthogonal planes.  75:175-183. 1987
  • Color Doppler evaluation of aortic dissection.  75:748-755. 1987
  • Cryosurgical treatment of atrioventricular node reentrant tachycardia.  76:1329-1336. 1987
  • Enhancement of cardioplegic protection with the free-radical scavenger peroxidase.  74. 1986
  • Enhancement of cardioplegic protection with the free-radical scavenger peroxidase..  74:III138-III144. 1986
  • Intermediate-term results of coronary artery bypass grafting for acute myocardial infarction..  72. 1985
  • Immediate functional recovery and avoidance of reperfusion injury with surgical revascularization of short-term coronary occlusion.  72:431-439. 1985
  • A randomized comparison of crystalloid and blood-containing cardioplegic solutions in 60 patients.  69:973-982. 1984
  • Return of left ventricular function after reperfusion in patients with myocardial infarction: Importance of subtotal stenoses or intact collaterals.  69:338-349. 1984
  • A life table and Cox regression analysis of patients with combined proximal left anterior descending and proximal left circumflex coronary artery disease: Non-left main equivalent lesions (CASS).  68:1163-1170. 1983
  • Correlation of echocardiographic wall stress and left ventricular pressure and function in aortic stenosis.  67:854-859. 1983
  • Evaluation of high-energy phosphate metabolism during cardioplegic arrest and reperfusion: A phosphorus-31 nuclear magnetic resonance study.  67:1296-1303. 1983
  • Variation in the size of jeopardized myocardium in patients with isolated left anterior descending coronary artery disease.  67:988-994. 1983
  • Costs and benefits associated with treatment for coronary artery disease.  66. 1982
  • Epidemiologic study of candidates for coronary artery bypass surgery..  66:III6-II15. 1982
  • Employment status after coronary artery bypass surgery.  65. 1982
  • Assessment of jeopardized myocardium in patients with one-vessel disease.  65:242-247. 1982
  • Epidemiologic study of candidates for coronary artery bypass surgery.  66. 1982
  • Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man.  66:49-55. 1982
  • Two-dimensional echocardiographic features of right ventricular infarction.  65:167-173. 1982
  • A simplified valve formula for the calculation of stenotic cardiac valve areas.  63:1050-1055. 1981
  • An automated system for blood pressure determination during exercise.  63:348-353. 1981
  • Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS).  64:360-367. 1981
  • Real-time, two-dimensional echocardiographic features of pacemaker perforation.  64:97-106. 1981
  • Two-dimensional echocardiographic features of atrial septal aneurysms.  63:452-457. 1981
  • Two-dimensional echocardiographic identification of papillary muscles..  64:651-652. 1981
  • Surgical vs nonsurgical management of patients after myocardial infarction.  62. 1980
  • Detection of residual jeopardized myocardium 3 weeks after myocardial infarction by exercise testing with thallium-201 myocardial scintigraphy.  61:729-737. 1980
  • Drug management of hypertension.  61:210-212. 1980
  • Unstable angina pectoris. An examination of modes and costs of therapy.  60. 1979
  • Effect of filming projection and interobserver variability on angiographic biplane left ventricular volume determination.  59:96-104. 1979
  • Impaired maximal rate of left ventricular relaxation in patients with coronary artery disease and left ventricular dysfunction.  59:984-991. 1979
  • Usefulness and limitations of thallium-201 myocardial scintigraphy in delineating location and size of prior myocardial infarction.  59:1010-1019. 1979
  • Anomalous aortic origin of coronary arteries.  58:606-615. 1978
  • Changes in left ventricular segmental wall motion following randomization to medicine or surgery in patients with unstable angina..  58. 1978
  • Echocardiographic evaluation of intracardiac pacing catheters: M-mode and two-dimensional studies.  58:1049-1056. 1978
  • Effect of glucose-insulin-potassium infusion during pacing.  58. 1978
  • Left ventricular aneurysmectomy in patients with single vs multivessel coronary artery disease..  58. 1978
  • The bruit of carotid stenosis versus radiated basal heart murmurs: Differentiation by phonoangiography.  57:975-981. 1978
  • The mechanism of post-arrhythmic renal vasoconstriction in the dog.  58. 1978
  • Correlation of angiographic estimates of myocardial infarct size and accumulated release of creatine kinase MB isoenzyme in man.  56:199-205. 1977
  • Improved outcome for prehospital cardiopulmonary collapse with resuscitation by bystanders.  56:901-905. 1977
  • Quantitative assessment of ventricular performance in unstable ischemic heart disease by dextran function curves.  55:858-863. 1977
  • Technetium 99m stannous pyrophosphate myocardial scintigraphy. Reliability and limitations in assessment of acute myocardial infarction.  56:192-198. 1977
  • Glucose insulin potassium, free fatty acids and acute myocardial infarction in man.  53. 1976
  • Anginal threshold and glucose-insulin-potassium in unstable ischemic heart disease.  54. 1976
  • Echocardiographic studies of abnormalities associated with coarctation of the aorta.  53:953-956. 1976
  • Echocardiography of cardiac valves in pericardial effusion.  54:500-504. 1976
  • Structural requirements for the inhibition of renin release in vitro by the angiotensins.  54. 1976
  • Simultaneous operative correction of aortic valve stenosis and idiopathic hypertrophic subaortic stenosis.  52:34-39. 1975
  • Echocardiographic features of subpulmonic obstruction in dextro transposition of the great vessels.  51:515-521. 1975
  • Echocardiography of the intra atrial baffle in dextro transposition of the great vessels.  51:1130-1135. 1975
  • Echocardiography of the tricuspid valve in congenital left ventricular right atrial communication.  51:268-272. 1975
  • Mitral commissurotomy versus replacement. Preoperative evaluation by echocardiography.  51:263-267. 1975
  • Echocardiographic evaluation of pulmonary hypertension.  50:575-581. 1974
  • Echocardiographic recognition of the congenital bicuspid aortic valve.  49:870-875. 1974
  • Echocardiography in the diagnosis of idiopathic hypertrophic subaortic stenosis co existing with aortic valve disease.  50:752-757. 1974
  • Diagnosis of aortic root dissection by echocardiography.  48:506-513. 1973
  • Echocardiographic assessment of left ventricular outflow width in the selection of mitral valve prosthesis..  48:1208-1214. 1973
  • Role of renin in acute postural homeostasis..  41:89-95. 1970
  • MiR-125b is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis.  CIRCULATIONAHA.115.018174-CIRCULATIONAHA.115.018174.
  • US Secular Trends in Coronary Heart Disease, Heart Attack/Myocardial Infarction, and Stroke Prevalence, by Race/Ethnicity, 2005-2010.  127.
  • International Standard Serial Number (issn)

  • 0009-7322
  • 1524-4539
  • Electronic International Standard Serial Number (eissn)

  • 1524-4539